imc-f106c
immunocore
['melanoma', 'imc-f106c']
#esmo22 updates: imc-f106c (prame cd3) show encouraging responses in heavily pre-treated pts esp. in cutaneous and uveal melanoma represents larger opportunities for development and further validation
#solidtumors #oncology #immunotherapy #tcellengager #bispecifics 
Course5i prides itself in enabling #LifeSciences organizations with insights, #analytics and #AI to drive strategic decisions. Enabling better health outcomes.